November 14, 2019 โ A large majority of patients with atherosclerotic cardiovascular disease (ASCVD) in the NCDR ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
November 6, 2019 โ Cleveland Clinicย announced the Top 10 Medical Innovations for 2020 at a multimedia presentation last ...
The latest in interventional cardiology clinical data and new device technologies were highlighted at the annual Transca ...
November 1, 2019 โ Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...
October 21, 2019 โ The U.S. Food and Drug Administration (FDA) has granted market clearance for AstraZeneca's ...
Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional ...
October 16, 2019 โ Researchers have shown for the first time in preclinical studies that the drug Aliskiren can delay ...
Ajay J. Kirtane, M.D., associate professor of medicine at Columbia University Irving Medical Center and director of the ...
Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional ...
American Heart Association President Robert Harrington, M.D., interventional cardiologist and the Arthur L. Bloomfield ...
September 30, 2019 โ The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug ...
September 30, 2019 โ A biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual ...
September 30, 2019 โ Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy ...
September 26, 2019 โ New data from the Phase IV independent TWILIGHT trial showed Brilinta (ticagrelor) monotherapy redu ...
September 20, 2019 โ Low-dose aspirin does not prolong disability-free survival of healthy people over 70, even in those ...